BUZZ-Australia's Curvebeam AI drops as Bell Potter cuts PT pending HiRise validation

Reuters

Sep 04, 2025

Sept 4 (Reuters) - ** Shares of Australia's Curvebeam AI CVB.AX down as much as 10.7% at A$0.125

** Analysts at Bell Potter cut price target for the medical equipment manufacturer to A$0.15 from A$0.18; downgrades recommendation to "hold" from "buy"

** Bell Potter lowers FY26 revenue forecasts for co to be in line with its FY25 results

** Brokerage says Curvebeam AI's sales of HiRise scanner will remain restrained as product hasn't been validated yet for use with Stryker's SYK.N Mako robotic surgery system

** Had expected HiRise's validation from Stryker would be completed in Q4FY26, albeit currently there is no guarantee it will be finalised within the current fiscal, says Bell Potter

** CVB last down 7.1%, bringing YTD losses to 3.7%

(Reporting by Keshav Singh Chundawat in Bengaluru)

((Keshav.SinghChundawat@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2564286003"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2564286003\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2564286003?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-04 13:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2564286003","market":"nz","top_or_hot":-1,"title":"BUZZ-Australia's Curvebeam AI drops as Bell Potter cuts PT pending HiRise validation","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's Curvebeam AI drops as Bell Potter cuts PT pending HiRise validation</title></head><body><p><span>Sept 4 (Reuters)</span><span> - </span>** Shares of Australia's Curvebeam AI <span>CVB.AX</span> down as much as 10.7% at A$0.125</p><p>** Analysts at Bell Potter cut price target for the medical equipment manufacturer to A$0.15 from A$0.18; downgrades recommendation to \"hold\" from \"buy\"</p><p>** Bell Potter lowers FY26 revenue forecasts for co to be in line with its FY25 results</p><p>** Brokerage says Curvebeam AI's sales of HiRise scanner will remain restrained as product hasn't been validated yet for use with Stryker's <span>SYK.N</span> Mako robotic surgery system</p><p>** Had expected HiRise's validation from Stryker would be completed in Q4FY26, albeit currently there is no guarantee it will be finalised within the current fiscal, says Bell Potter</p><p>** CVB last down 7.1%, bringing YTD losses to 3.7%</p><p> (Reporting by Keshav Singh Chundawat in Bengaluru)</p><p> ((Keshav.SinghChundawat@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Curvebeam AI drops as Bell Potter cuts PT pending HiRise validation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Curvebeam AI drops as Bell Potter cuts PT pending HiRise validation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-04 13:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's Curvebeam AI drops as Bell Potter cuts PT pending HiRise validation</title></head><body><p><span>Sept 4 (Reuters)</span><span> - </span>** Shares of Australia's Curvebeam AI <span>CVB.AX</span> down as much as 10.7% at A$0.125</p><p>** Analysts at Bell Potter cut price target for the medical equipment manufacturer to A$0.15 from A$0.18; downgrades recommendation to \"hold\" from \"buy\"</p><p>** Bell Potter lowers FY26 revenue forecasts for co to be in line with its FY25 results</p><p>** Brokerage says Curvebeam AI's sales of HiRise scanner will remain restrained as product hasn't been validated yet for use with Stryker's <span>SYK.N</span> Mako robotic surgery system</p><p>** Had expected HiRise's validation from Stryker would be completed in Q4FY26, albeit currently there is no guarantee it will be finalised within the current fiscal, says Bell Potter</p><p>** CVB last down 7.1%, bringing YTD losses to 3.7%</p><p> (Reporting by Keshav Singh Chundawat in Bengaluru)</p><p> ((Keshav.SinghChundawat@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1791710582.SGD","symbol_name":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nL4N3UR0AU:1","article_id":"2564286003","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564286003","pubTimestamp":1756964309,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's Curvebeam AI drops as Bell Potter cuts PT pending HiRise validationSept 4 (Reuters) - ** Shares of Australia's Curvebeam AI CVB.AX down as much as 10.7% at A$0.125** Analysts at Bell ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","BK7007":"医疗保健设备","BK4585":"ETF&股票定投概念","GB00B4QBRK32.GBP":"FUNDSMITH EQUITY \"R\" (GBP) INC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","GB00B4LPDJ14.GBP":"FUNDSMITH EQUITY \"R\" (GBP) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","BK4566":"资本集团","LU2404859741.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU2404859667.USD":"FUNDSMITH EQUITY FUND \"R\" (USD) ACC","BK4082":"医疗保健设备","BK4504":"桥水持仓","LU0058720904.USD":"联博国际健康护理基金A","LU0690374961.EUR":"FUNDSMITH EQUITY \"R\" (EUR) INC","BK4588":"碎股","CVB.AU":"CurveBeam AI Limited","SYK":"史赛克","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU0690374615.EUR":"FUNDSMITH EQUITY \"R\" (EUR) ACC","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC"},"translate_title":"BUZZ-澳大利亚Curvebeam AI下跌，Bell Potter削减PT等待HiRise验证","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CVB.AU":0.9,"SYK":0.9},"content_text":"BUZZ-Australia's Curvebeam AI drops as Bell Potter cuts PT pending HiRise validationSept 4 (Reuters) - ** Shares of Australia's Curvebeam AI CVB.AX down as much as 10.7% at A$0.125** Analysts at Bell Potter cut price target for the medical equipment manufacturer to A$0.15 from A$0.18; downgrades recommendation to \"hold\" from \"buy\"** Bell Potter lowers FY26 revenue forecasts for co to be in line with its FY25 results** Brokerage says Curvebeam AI's sales of HiRise scanner will remain restrained as product hasn't been validated yet for use with Stryker's SYK.N Mako robotic surgery system** Had expected HiRise's validation from Stryker would be completed in Q4FY26, albeit currently there is no guarantee it will be finalised within the current fiscal, says Bell Potter** CVB last down 7.1%, bringing YTD losses to 3.7% (Reporting by Keshav Singh Chundawat in Bengaluru) ((Keshav.SinghChundawat@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}